Quality of life in patients with recurrent ovarian cancer (OC) treated with niraparib: Results from the ENGOT-OV16/NOVA trial

A. M. Oza, U. A. Matulonis, S. Malander, J. Sehouli, J. M. del Campo, D. Berthon-Rigaud, S. Banerjee, G. Scambia, J. S. Berek, Bente Lund, A. V. Tinker, F. Hilpert, I. Palacio Vázquez, V. D’hondt, B. Benigno, D. M. Provencher, J. Buscema, S. Hudgens, S. Agarwal, M. R. Mirza

Research output: Contribution to journalConference abstract in journalResearchpeer-review

Original languageEnglish
Article number930O
JournalAnnals of Oncology
Volume28
Issue numberSuppl. 5
Pages (from-to)330
Number of pages1
ISSN0923-7534
Publication statusPublished - 2017
EventEuropean Society for Medical Oncology (ESMO) 2017: Integrating science into oncology for a better patient outcome - Madrid, Spain
Duration: 8 Sep 201712 Sep 2017
http://www.esmo.org/Conferences/ESMO-2017-Congress

Conference

ConferenceEuropean Society for Medical Oncology (ESMO) 2017
CountrySpain
CityMadrid
Period08/09/201712/09/2017
Internet address

Cite this